AMGN
Amgen IncBiological Products, (No Diagnostic Substances)
$385.65updated Sep 19, 2026
Congressional trading profile for Amgen Inc (AMGN), covering 36 disclosed transactions by 13 lawmakers.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Total Trades
36
Politicians Trading
13
Last Traded
Aug 26, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| David TaylorR | Sep 5, 2026 | Aug 26, 2026 | Sell | $1,001 - $15,000 | -12.42% |
| David TaylorR | Sep 5, 2026 | Aug 26, 2026 | Sell | $1,001 - $15,000 | -12.42% |
| Sheldon WhitehouseD | Sep 2, 2026 | Aug 12, 2026 | Sell | $1,001 - $15,000 | -7.34% |
| Ro KhannaD | Aug 7, 2026 | Jul 20, 2026 | Sell | $1,001 - $15,000 | +5.90% |
| Alan ArmstrongR | Jul 21, 2026 | Mar 27, 2026 | Sell | $15,001 - $50,000 | +10.57% |
| Ro KhannaD | Jun 9, 2026 | May 15, 2026 | Sell | $15,001 - $50,000 | +18.19% |
| Ro KhannaD | May 11, 2026 | Apr 24, 2026 | Sell | $15,001 - $50,000 | +11.93% |
| David TaylorR | Mar 6, 2026 | Feb 26, 2026 | Sell | $1,001 - $15,000 | +1.67% |
| David TaylorR | Feb 2, 2026 | Jan 29, 2026 | Sell | $1,001 - $15,000 | +12.45% |
| David TaylorR | Dec 5, 2025 | Dec 3, 2025 | Sell | $1,001 - $15,000 | +11.65% |
| David TaylorR | Dec 5, 2025 | Dec 3, 2025 | Sell | $1,001 - $15,000 | +11.65% |
| Lisa C. McClainR | Oct 22, 2025 | Sep 25, 2025 | Sell | $1,001 - $15,000 | +42.21% |
| Sheldon WhitehouseD | Oct 3, 2025 | Sep 4, 2025 | Sell | $1,001 - $15,000 | +37.68% |
| Daniel MeuserR | Aug 20, 2025 | Feb 11, 2025 | Sell | $1,001 - $15,000 | +30.00% |
| Jefferson ShreveR | Jun 22, 2025 | May 12, 2025 | Sell | $15,001 - $50,000 | +40.36% |
| Tommy TubervilleR | May 15, 2025 | Apr 15, 2025 | Sell | $15,001 - $50,000 | +30.60% |
| Robert BresnahanR | May 8, 2025 | Apr 8, 2025 | Sell | $1,001 - $15,000 | +37.60% |
| Emily RandallD | Feb 11, 2025 | Jan 6, 2025 | Sell | $1,001 - $15,000 | +49.14% |